Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Chiesi USA, Inc. recalls Revcovi (elapegademase-lvlr) Injection

Class IIIofficial

FDA Class III

FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).

Hazard
Failed Stability Specifications: Out of specification stability result for the protein concentration profile.
Products
  • Revcovi (elapegademase-lvlr) Injection
Where it was sold

MO, TN

States: Missouri, Tennessee

Units affected
3,002 vials
About this recall
Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Only, For Intramuscular Use Only, Mfd. by Chiesi USA, Inc., Cary, NC 27518, NDC 10122-502-01